Results 1 to 10 of about 723,767 (301)

A Systematic and a Scoping Review on the Psychometrics and Clinical Utility of the Volume-Viscosity Swallow Test (V-VST) in the Clinical Screening and Assessment of Oropharyngeal Dysphagia

open access: yesFoods, 2021
(1) Background: The volume-viscosity swallow test (V-VST) is a clinical tool for screening and diagnosis of oropharyngeal dysphagia (OD). Our aims were to examine the clinical utility of the V-VST against videofluoroscopy (VFS) or fiberoptic endoscopic ...
Stephanie A. Riera   +7 more
doaj   +1 more source

Objective assessment of eye alignment and disparity-driven vergence in Parkinson’s disease

open access: yesFrontiers in Aging Neuroscience, 2023
BackgroundSelf-reported diplopia is described in up to one-third of Parkinson’s disease (PD) patients.ObjectiveThe purpose of our study was to expand our understanding of the mechanistic underpinnings of diplopia in PD. We hypothesize that the time-based
Palak Gupta   +12 more
doaj   +1 more source

Effects of in vitro lipid overload on LX-2 hepatic stellate cells

open access: yesAnnals of Hepatology, 2022
Introduction and Objectives: Studying lipid overload repercussions on hepatic stellate cells (HSC) is of great importance due to their role in fibrosis during NAFLD. Steatogenic cell culture of HSC is intended to elucidate pathogenic mechanisms in NAFLD.
A Campos-Espinosa   +2 more
doaj   +1 more source

Loss of Unconventional Myosin VI Affects cAMP/PKA Signaling in Hindlimb Skeletal Muscle in an Age-Dependent Manner

open access: yesFrontiers in Physiology, 2022
Myosin VI (MVI) is a unique unconventional myosin ubiquitously expressed in metazoans. Its diverse cellular functions are mediated by interactions with a number of binding partners present in multi-protein complexes.
Lilya Lehka   +5 more
doaj   +1 more source

A new interpretation and quantitative method for diplopia test: 304 cases of ocular motor nerve palsy for clinical test and verify [PDF]

open access: yesInternational Journal of Ophthalmology, 2017
We introduce a new interpretation and quantitative method for computerized diplopia test. By comparing this new method to the Hess screen test, we validate its applicability among 304 patients with ocular motor nerve palsy.
Ling-Yun Zhou   +5 more
doaj   +1 more source

Assessment of cellular proliferation, death and senescence in a model of steatosis in vitro

open access: yesAnnals of Hepatology, 2022
Introduction and objectives: Hepatocyte cell culture in steatogenic medium is a useful, reproducible tool. During NAFLD, cells undergo processes in response to the steatogenic input. Here we aimed to study cellular proliferation, death, and senescence in
A Campos-Espinosa   +2 more
doaj   +1 more source

How myosin VI traps its off-state, is activated and dimerizes

open access: yesNature Communications, 2023
Myosin VI (Myo6) is the only minus-end directed nanomotor on actin, allowing it to uniquely contribute to numerous cellular functions. As for other nanomotors, the proper functioning of Myo6 relies on precise spatiotemporal control of motor activity via ...
Louise Canon   +22 more
doaj   +1 more source

A Unifying Model-Based Hypothesis for the Diverse Waveforms of Infantile Nystagmus Syndrome

open access: yesJournal of Eye Movement Research, 2011
We expanded the original behavioral Ocular Motor System (OMS) model for Infantile Nystagmus Syndrome (INS) by incorporating common types of jerk waveforms within a unifying mechanism.
Zhong I. Wang, Louis F. Dell'Osso
doaj   +1 more source

Myosin 7 and its adaptors link cadherins to actin

open access: yesNature Communications, 2017
Cadherin is essential for mechanotransduction and myosin-adaptor-harmonin complexes anchor it to actin. Here the authors present the structures of myosin 7 MF2 domains bound to the harmonin PDZ3c domain and give insights into myosin-adaptor-harmonin ...
I-Mei Yu   +8 more
doaj   +1 more source

Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil

open access: yesNature Communications, 2017
Omecamtiv mecarbil (OM) is a cardiac myosin activator that is currently in clinical trials for heart failure treatment. Here, the authors give insights into its mode of action and present the crystal structure of OM bound to bovine cardiac myosin, which ...
Vicente J. Planelles-Herrero   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy